Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-27
2011-10-25
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021500, C530S326000, C530S345000
Reexamination Certificate
active
08044019
ABSTRACT:
According to the present invention, it is possible to provide a novel cell penetrating peptide that transports proteins into cells and/or into nuclei at higher frequency than conventional cell penetrating peptides, and a pharmaceutical containing the peptide.
REFERENCES:
patent: 2004/0034888 (2004-02-01), Liu et al.
patent: 2003-252802 (2003-09-01), None
patent: WO 98/20016 (1998-05-01), None
patent: WO 9846750 (1998-10-01), None
patent: WO 02/18572 (2002-03-01), None
patent: WO 03/097671 (2003-11-01), None
Shiro Niki, et al., “Maku Toka Peptide o Mochiita Tanpakushitsu Saibonai Iso”, Kagaku to Seibutsu, vol. 43, No. 10, Oct. 1, 2005, pp. 649-653.
Kenji Kono, et al., “Saibo no Naka eno Chokkobin-Maku Toka Peptide o Hyomei ni Motsu”, Ribosome Chemical, vol. 57, No. 6, 2002, pp. 51-52.
Thomas Plénat, et al., “Interaction of Primary Amphipathic Cell-Penetrating Peptides with Phospholipid-Supported Monolayers”, Langmuir, vol. 20, No. 21, 2004, pp. 9255-9261.
Yousuke Nishio, et al, “Comparative Complete Genome Sequence Analysis of the Amino Acid Replacements Responsible for the Thermostability ofCorynebacterium efficiens”, Genome Research, vol. 13, 2003, pp. 1572-1579.
Satoshi {hacek over (O)}mura, et al., “Genome sequence of an industrial microorganismStreptomyces avermitlis: Deducing the ability of producing secondary metabolites”, Proc. Natl. Acad. Sci. USA, vol. 98, No. 21, 2001, pp. 12215-12220.
F. O. Glöckner, et al., “Complete genome sequence of the marine planctomycetePirellulasp. Strain 1”, Proc. Natl. Acad. Sci. USA, vol. 100, No. 14, 2003, pp. 8298-8303.
Olivier Jaillon, et al., “Genome duplication in the teleost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype”, Nature, vol. 431, 2004, pp. 946-957.
Tatyana V. Golovkina, et al., “A Novel Membrane Protien Is a Mouse Mammary Tumor Virus Receptor”, Journal of Virology, vol. 72, No. 4, XP 002497675, Apr. 1998, pp. 3066-3071.
Kenji Kokura, et al., “The Ski-Binding Protien C184M Negatively Regulates Tumor Growth Factor-β Signaling by Sequestering the Smad Protiens in the Cytoplasm”, The Journal of Biological Chemestry, vol. 278, No. 22, XP 002497676, May 2003, pp. 20133-20139.
Joaquin Royo, et al., “Characterzation of Three Potato Lipoxygenases with Distinct Enzymatic Activities and Different Organ-Specific and Wound-Regulated Expression Patterns”, The Journal of Biological Chemistry, vol. 271, No. 35, XP 002186561, Aug. 30, 1996, pp. 21012-21019.
Kamide Kaeko
Nakakubo Hiroshi
Uno Shusei
Mitsubishi Tanabe Pharma Corporation
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Russel Jeffrey E
LandOfFree
Cell penetrating peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell penetrating peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell penetrating peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4295760